Reverse iontophoretic monitoring in premature neonates: feasibility and potential.
暂无分享,去创建一个
R H Guy | Y. Kalia | A. Naik | R. Guy | P. Glikfeld | Y N Kalia | N Sekkat | A Naik | P Glikfeld | N. Sekkat | Nabila Sekkat | Richard H. Guy
[1] R. Guy,et al. A New System for In Vitro Studies of Iontophoresis , 1988, Pharmaceutical Research.
[2] J. Miners,et al. The simultaneous determination of theophylline, theobromine and caffeine in plasma by high performance liquid chromatography. , 1980, Clinical biochemistry.
[3] W. Hop,et al. Use of Saliva in Therapeutic Drug Monitoring of Caffeine in Preterm Infants , 2001, Therapeutic drug monitoring.
[4] A S Gross. Best practice in therapeutic drug monitoring. , 1998, British journal of clinical pharmacology.
[5] J. Hadgraft,et al. The back diffusion of glucose across human skin in vitro , 1999 .
[6] K. Sugibayashi,et al. Non-invasive sampling of lactic acid ions by iontophoresis using chloride ion in the body as an internal standard. , 1993, Journal of Pharmaceutical and Biomedical Analysis.
[7] J. McCormack,et al. Drug Concentration Monitoring , 1993, Clinical pharmacokinetics.
[8] J. Blumer,et al. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II). , 1988, Clinical pharmacokinetics.
[9] G. Koren. Therapeutic drug monitoring principles in the neonate , 1997 .
[10] V. Langer. Minimal handling protocol for the intensive care nursery. , 1990, Neonatal network : NN.
[11] P. Gal,et al. Usefulness of theophylline saliva levels in neonates. , 1983, Therapeutic drug monitoring.
[12] P. Steer,et al. Saliva as a valid alternative to serum in monitoring intravenous caffeine treatment for apnea of prematurity. , 1996, Therapeutic drug monitoring.
[13] Richard H. Guy,et al. Noninvasive Sampling of Biological Fluids by Iontophoresis , 1989, Pharmaceutical Research.
[14] L. Jovanovic,et al. Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team. , 1999, JAMA.
[15] R. Guy,et al. Reverse iontophoresis — parameters determining electro-osmotic flow. II. Electrode chamber formulation , 1996 .
[16] R O Potts,et al. Detection of hypoglycemia with the GlucoWatch biographer. , 2001, Diabetes care.
[17] R. Guy,et al. Noninvasive sampling of phenylalanine by reverse iontophoresis. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[18] R. Guy,et al. Characterization of Convective Solvent Flow During Iontophoresis , 1994, Pharmaceutical Research.
[19] Susan Budavari,et al. The Merck index , 1998 .
[20] J. Blumer,et al. Principles of Drug Biodisposition in the Neonate , 2012 .
[21] G. Budreau,et al. Clinical indicators of infant irritability. , 1991, Neonatal network : NN.
[22] R. Guy,et al. Reverse iontophoresis — Parameters determining electroosmotic flow: I. pH and ionic strength , 1996 .
[23] R H Guy,et al. Characterization of the iontophoretic permselectivity properties of human and pig skin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[24] R H Guy,et al. Transdermal therapy and diagnosis by iontophoresis. , 1997, Trends in biotechnology.
[25] N. Rutter,et al. Transdermal delivery and the premature neonate. , 1994, Critical reviews in therapeutic drug carrier systems.
[26] G. Merenstein,et al. Transcutaneous theophylline collection in preterm infants , 1990, Clinical pharmacology and therapeutics.